In another study by Park et al. (21), plasma H-FABP was shown to be increased in the acute phase of ischemic stroke; however, the diagnostic accuracy of H-FABP as a sole marker was not considered sufficient to be used in the clinical setting. The gene discussed is FABP3; the disease is ischemic stroke.